PRESS RELEASE published on 03/13/2025 at 14:00, 1 year 7 months ago Vox Royalty Provides Development Updates and Approval of 2025 Share Repurchase Program Vox Royalty Corp. provides updates on mining royalty partners Black Cat Syndicate Limited, Orla Mining Ltd., and Galway Metals Inc. Recent developments include new acquisitions and progress towards production in Western Australia, Nevada, and Quebec Acquisitions Vox Royalty Corp. Production Mining Royalty Partners
PRESS RELEASE published on 03/13/2025 at 13:45, 1 year 7 months ago bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne bonyf secures EU Patent, pending US patent, for PerioTabs® & PerioCream, set to launch at IDS Cologne in March 2025. Products aim to revolutionize dental care practices globally Bonyf PerioTabs EU Patent PerioCream IDS Cologne
PRESS RELEASE published on 03/13/2025 at 13:41, 1 year 7 months ago Form 8.3 - Equals Group PLC Chelverton Asset Management discloses a 1.18% stake in Equals Group PLC. No other disclosures made Stake Chelverton Asset Management Equals Group PLC Disclosures 1.18%
PRESS RELEASE published on 03/13/2025 at 13:38, 1 year 7 months ago REPLY: The Board of Directors approved the draft financial statements for the year 2024 Reply S.p.A. Board of Directors approves draft financial statements for 2024, proposing dividend distribution of €1.15 per share. Positive financial indicators with increased turnover and net profit Board Of Directors Financial Statements Dividend Distribution Reply S.p.A. Positive Indicators
PRESS RELEASE published on 03/13/2025 at 13:30, 1 year 7 months ago Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses Xenetic Biosciences presents promising findings on combining DNase I with CAR T cells to enhance cancer treatment strategies at the SITC Spring Scientific 2025 Cell Therapy Meeting Xenetic Biosciences Cancer Treatment DNase I CAR T Cells SITC Spring Meeting
PRESS RELEASE published on 03/13/2025 at 13:30, 1 year 7 months ago Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform Aspire Biopharma Holdings, Inc. provides update on patent applications for Oral Mucosal Formulations of Aspirin with rapid absorption technology. Company aims to revolutionize drug delivery and improve patient outcomes Drug Delivery Technology Patent Applications Aspire Biopharma Oral Mucosal Formulations Aspirin
PRESS RELEASE published on 03/13/2025 at 13:18, 1 year 7 months ago Informations privilégiées / Autres communiqués L'Autorité de la concurrence valide l'acquisition de Galimmo par Carmila. Carmila cèdera la galerie commerciale de Villers Semeuse en 2025 Cession Acquisition Autorité De La Concurrence CARMILA Galimmo
PRESS RELEASE published on 03/13/2025 at 13:18, 1 year 7 months ago Inside Information / Other news releases French Competition Authority approves Carmila's acquisition of Galimmo, Carmila to sell Villers Semeuse shopping gallery in 2025. No significant impact on financial targets Acquisition Competition Authority CARMILA Galimmo Villers Semeuse
PRESS RELEASE published on 03/13/2025 at 13:00, 1 year 7 months ago Prince Holding Group Earns Fifth Consecutive ‘Best in Cambodia’ Award for CSR Initiatives Prince Holding Group recognized as 'Best in Country Excellence - Best in Cambodia' at the 17th Annual Global CSR & ESG Awards for sustainable development efforts. Awards highlight ongoing CSR and ESG initiatives guided by Chairman Chen Zhi Sustainable Development Prince Holding Group Chen Zhi CSR Initiatives Global CSR Awards
PRESS RELEASE published on 03/13/2025 at 13:00, 1 year 7 months ago MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain MIRA Pharmaceuticals introduces topical Ketamir-2 for neuropathic and inflammatory pain, expanding pain management portfolio with innovative targeted approach MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain Topical Treatment Inflammatory Pain
Published on 10/16/2026 at 15:45, 3 hours 5 minutes ago IBC Advanced Alloys Reports Improved Financial Results for the Year Ended June 2026
Published on 10/16/2026 at 13:40, 5 hours 10 minutes ago Stagwell (STGW) Appoints Nagmeh Taheri to Chief Growth Officer, Media & Commerce for Stagwell Europe
Published on 10/16/2026 at 13:30, 5 hours 20 minutes ago AirIQ Announces Appointment of Interim Chief Financial Officer
Published on 10/16/2026 at 13:30, 5 hours 20 minutes ago NuRAN Wireless CEO to Meet African Telecom Leaders as Company Advances Tower Rollout and Next Phase of Growth
Published on 10/16/2026 at 18:13, 37 minutes ago EQS-Adhoc: DHL AG: DHL AG raises full-year 2026 earnings guidance
Published on 10/16/2026 at 17:50, 1 hour ago Brazilian Fernanda Maciel Sets Salar de Uyuni Fastest Known Time of 19:50:08
Published on 10/16/2026 at 17:45, 1 hour 5 minutes ago EUROPLASMA: Actualisation du projet de cession du Pôle Défense et priorités du Groupe
Published on 10/16/2026 at 07:30, 11 hours 20 minutes ago Chiffre d'affaires du troisième trimestre 2026
Published on 10/15/2026 at 18:50, 1 day ago September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
Published on 10/15/2026 at 18:50, 1 day ago Trafic du mois de septembre et des 9 premiers mois de l'année 2026 - Révision des hypothèses de trafic pour l'année 2026